FindTrial
Sign In

A clinical study of early diagnostic markers of acute kidney injury in sepsis by metabonomics

A clinical study of early diagnostic markers of acute kidney injury in sepsis by metabonomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012150
Enrollment
Unknown
Registered
2017-07-26
Start date
2017-08-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis-induced acute kidney injury

Interventions

Gold Standard:Serum creatinine
Index test:metabolomics&#32
technology

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Aged 40-70 years old; 2) Complies with sepsis 3.0 diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1) patients with liver dysfunction; 2) clear diagnosis or clinical suspected acute renal injury in patients caused by obstructive nephropathy; 3) patients with chronic renal failure needed regular dialysis patients; 4) patients with metastatic tumors.

Design outcomes

Primary

MeasureTime frame
Serum creatinine;SPE;SEN;ACC;—

Countries

China

Contacts

Public ContactLiyingchuan

Shanghai Sixth People's Hospital

yingchuan.li@sjtu.edu.cn18930177526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026